The Lancet Infectious Diseases
Volume 19, Issue 10, 2019, Pages e352-e359

Severe disseminated tuberculosis in HIV-negative refugees (Review)

Suárez I. , Maria Fünger S. , Jung N. , Lehmann C. , Reimer R.P. , Mehrkens D. , Bunte A. , Plum G. , Jaspers N. , Schmidt M. , Fätkenheuer G.* , Rybniker J.
  • a Department I of Internal Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany, German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany
  • b Department I of Internal Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany
  • c Department I of Internal Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany
  • d Department I of Internal Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany, German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
  • e Institute of Diagnostic and Interventional Radiology, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany
  • f Department of Cardiovascular Medicine, University Heart Center, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
  • g Public Health Department Cologne, Cologne, Germany
  • h Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany
  • i Department of Gastroenterology and Hepatology, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany
  • j Department for Nuclear Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany
  • k Department I of Internal Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany, German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany
  • l Department I of Internal Medicine, Faculty of Medicine, University of Cologne and University Hospital Cologne, Cologne, Germany, German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Abstract

In high-income countries, the presentation of tuberculosis is changing, primarily because of migration, and understanding the specific health needs of susceptible populations is becoming increasingly important. Although disseminated tuberculosis is well documented in HIV-positive patients, the disease is poorly described and less expected in HIV-negative individuals. In this Grand Round, we report eight HIV-negative refugees, who presented with extensively disseminated tuberculosis. We discuss the multifactorial causes, such as deprivations during long journeys, precarious living conditions, and the experience of violence, which might add to nutritional factors and chronic disorders, eventually resulting in a state of predisposition to immune deficiency. We also show that disseminated tuberculosis is often difficult to diagnose when pulmonary symptoms are absent. Communication difficulties between refugees and health-care workers are another major hurdle, and every effort should be made to get a valid patient history. This medical history is crucial to guide imaging and other diagnostic procedures to establish a definite diagnosis, which should be confirmed by a positive tuberculosis culture. Because many of these patients are at risk for multidrug-resistant tuberculosis, drug susceptibility testing is imperative to guide therapy. In the absence of treatment guidelines for this entity, clinicians can determine treatment duration according to recommendations provided for extrapulmonary tuberculosis and affected organs. Paradoxical expansion of tuberculous lesions during therapy should be treated with corticosteroids. In many cases, treatment duration must be individualised and might even exceed 12 months. © 2019 Elsevier Ltd

Author Keywords

[No Keywords available]

Index Keywords

treatment response extrapulmonary tuberculosis erythrocyte sedimentation rate refugee spleen abscess backache body temperature clinical feature leg pain human Vitamin D prednisolone priority journal lymphocytopenia doxycycline laboratory test diagnostic imaging tazobactam immunosuppressive treatment treatment duration lung tuberculosis granulomatous inflammation gamma glutamyltransferase lung lavage transthoracic echocardiography clinical examination abdominal tumor Treatment Outcome fluorodeoxyglucose f 18 piperacillin liver abscess Review recurrent fever arm pain chronic cough ocular tuberculosis clinical article polymerase chain reaction vitamin D deficiency infection control body weight gain C reactive protein adult antibiotic therapy isoniazid health care access vitamin supplementation disease predisposition medical history histopathology immune deficiency ethambutol exposure to violence rifampicin body mass Physical Examination pyrazinamide bacterium culture miliary tuberculosis
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072527216&doi=10.1016%2fS1473-3099%2819%2930162-8&partnerID=40&md5=54b9e3edf09df2246dc502e421bcca38
DOI: 10.1016/S1473-3099(19)30162-8
ISSN: 14733099
Cited by: 1
Original Language: English